This interview with CEO Dr. Michelle Miller presents an excellent overview of the state of the company and the market (although even in the 4 months since there has been significant advances in treatment trials)
http://www.youtube.com/watch?v=M3-W2XVKR0g
Surely Gilead will not be able to dominate a multi billion dollar market opportunity for long and hopefully BIT-225 is part of a treatment regime that picks up a share of the pie.
....and don't underestimate the HIV treatment potential
I'm with you Denton, here's cheers to all the longtermers right back to Tawny Port many years ago.
GLTA
FF
This interview with CEO Dr. Michelle Miller presents an...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.0¢ |
Change
0.005(11.1%) |
Mkt cap ! $45.11M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 5.2¢ | 4.6¢ | $42.25K | 871.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 155000 | 2 |
View Market Depth
| Last trade - 15.51pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.0¢ |
Change
0.005 ( 8.70 %) |
||||
| Open | High | Low | Volume | ||
| 4.6¢ | 5.1¢ | 4.6¢ | 221683 | ||
| Last updated 15.49pm 14/06/2024 ? | |||||
| BIT (ASX) Chart |